Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Riber Regulatory Filings 2012

Mar 22, 2012

1629_iss_2012-03-22_452133ff-f3e6-4ece-ad21-d2bbe05785f7.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Order for a research machine in Russia

Bezons, March 22nd, 2012 – 5:45 pm – RIBER, the global leader for molecular beam epitaxy (MBE), is announcing the sale of a research system to a leading research institute based in Russia.

This order, supplying one Epineat model MBE machine in 2012, will develop laboratory's research capacities on III-V components.

The Epineat system represents the most effective solution for basic research of compound semiconductor materials on 4-inch substrates.

These new order confirms RIBER's growing reputation among the scientific community in Russia, where the semiconductor industry is booming.

About RIBER:

Riber designs and produces molecular beam epitaxy (MBE) systems as well as evaporation sources and cells for the semiconductor industry. This high-technology equipment is essential for the manufacturing of compound semiconductor materials and new materials that are used in numerous consumer applications, such as new information technologies, OLED flat screens and new generation solar cells.

Riber is listed on Euronext Paris Compartment "C" and is part of the CAC Small, CAC Mid & Small and CAC IT indexes.

ISIN: FR0000075954 Reuters code: RIBE.PA Bloomberg code: RIB: FP

Riber has been innovation certified by OSEO, the dedicated French innovation agency, enabling it to qualify for French innovation mutual funds (FCPI).

RIBER CALYPTUS
Olivier Handschumacher Cyril Combe
tel: +33 1 39 96 65 00 tel: +33 1 53 65 68 68
[email protected] [email protected]

www.riber.com